Benzinga | Aug 4, 2020 04:47PM EDT

CytoSorbents Q2 EPS $(0.08), Inline, Sales $9.79M Beat $9.66M Estimate

CytoSorbents (NASDAQ:CTSO) reported quarterly losses of $(0.08) per share which met the analyst consensus estimate. This is a 27.27 percent increase over losses of $(0.11) per share from the same period last year. The company reported quarterly sales of $9.79 million which beat the analyst consensus estimate of $9.66 million by 1.40 percent. This is a 57.17 percent increase over sales of $6.23 million the same period last year.